New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
bioAffinity Technologies, Inc.
BIAF
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

18M

Medical - Diagnostics & Research

Next Earning date - 12 Nov 2024

18M

Medical - Diagnostics & Research

Next Earning date - 12 Nov 2024

1.32USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-59%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

64%

Quote Panel

Shape
Updated November 8, 2024
1W -4.35 % 1M -33.67 % 3M -25.84 % 1Y -10.81 %

Key Metrics

Shape
  • Market Cap

    17.81M


  • Shares Outstanding

    13.49M


  • Share in Float

    7.45M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    1.32


  • Average Volume

    115181


  • Beta

    3.124


  • Range

    1.25-3.62


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.bioaffinitytech.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.43x

P/S Ratio

4.38x

P/B Ratio

0.1

Debt/Equity

-119.4%

Net Margin

$-0.9

EPS

How BIAF compares to sector?

P/E Ratio

Relative Strength

Shape

BIAF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$11M

Shape379%

2025-Revenue

$0.60

Shape-216%

2025-EPS

$2M

Shape219%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-1.10
vs -0.55

Q4.22

arrow
arrow

N/A

-0.20
vs -2.04

Q1.23

arrow
arrow

N/A

-0.18
vs -0.54

Q2.23

arrow
arrow

N/A

-0.20
vs -0.18

Q3.23

arrow
arrow

N/A

-0.26
vs -1.10

Q4.23

arrow
arrow

N/A

-0.26
vs -0.20

Q1.24

arrow
arrow

N/A

-0.21
vs -0.18

Q2.24

arrow
arrow

N/A

-0.19
vs -0.20

Q3.24

arrow
arrow

N/A

-0.15
vs -0.26

Q4.24

arrow
arrow

N/A

-0.14
vs -0.26

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

1.1K  vs NA

Q4.22

arrow
arrow

NA

2.3K  vs NA

Q1.23

arrow
arrow

NA

921  vs NA

Q2.23

arrow
arrow

+1411%

19.7K  vs 1.3K

Q3.23

arrow
arrow

+25855%

298.5K  vs 1.1K

Q4.23

arrow
arrow

+94246%

2.2M  vs 2.3K

Q1.24

arrow
arrow

+261180%

2.4M  vs 921

Q2.24

arrow
arrow

+12047%

2.4M  vs 19.7K

Q3.24

arrow
arrow

+751%

2.5M  vs 298.5K

Q4.24

arrow
arrow

+20%

2.6M  vs 2.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-39%

-0.39
vs 0.03

Q4.22

arrow
arrow

-15%

-0.15
vs -0.39

Q1.23

arrow
arrow

-16%

-0.16
vs -0.15

Q2.23

arrow
arrow

-21%

-0.21
vs -0.16

Q3.23

arrow
arrow

-33%

-0.33
vs -0.21

Q4.23

arrow
arrow

-49%

-0.49
vs -0.33

Q1.24

arrow
arrow

-37%

-0.37
vs -0.49

Q2.24

arrow
arrow

-61%

-0.61
vs -0.37

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News